Clinical Trial Update: Patient's Derived Organoids for Drug Screening in Glioblastoma [NA]

View source ↗

Summary

The study aims to use patient-derived glioblastoma organoids to screen potential drugs, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Glioblastoma, Glioblastoma Multiforme (GBM) | NA | Status: NOT_YET_RECRUITING